 Duncan Wilcox
Concepts (546)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Bladder | 28 | 2025 | 194 | 4.870 |
Why?
| | Cloaca | 19 | 2025 | 52 | 3.590 |
Why?
| | Urologic Surgical Procedures | 19 | 2025 | 115 | 2.980 |
Why?
| | Hypospadias | 7 | 2022 | 31 | 2.660 |
Why?
| | Urinary Bladder Neck Obstruction | 5 | 2023 | 20 | 2.170 |
Why?
| | Urogenital Abnormalities | 10 | 2023 | 71 | 2.100 |
Why?
| | Anorectal Malformations | 10 | 2024 | 113 | 1.800 |
Why?
| | Urinary Bladder, Neurogenic | 6 | 2024 | 44 | 1.780 |
Why?
| | Urodynamics | 8 | 2025 | 47 | 1.780 |
Why?
| | Urethra | 11 | 2020 | 57 | 1.740 |
Why?
| | Lower Urinary Tract Symptoms | 6 | 2024 | 59 | 1.690 |
Why?
| | Hydronephrosis | 7 | 2015 | 35 | 1.520 |
Why?
| | Urology | 8 | 2024 | 64 | 1.380 |
Why?
| | Urogenital System | 4 | 2023 | 17 | 1.370 |
Why?
| | Spinal Dysraphism | 7 | 2025 | 114 | 1.300 |
Why?
| | Ureteral Obstruction | 5 | 2022 | 62 | 1.240 |
Why?
| | Urinary Bladder, Overactive | 2 | 2021 | 23 | 1.210 |
Why?
| | Circumcision, Male | 2 | 2019 | 16 | 1.010 |
Why?
| | Hirschsprung Disease | 9 | 2024 | 91 | 1.000 |
Why?
| | Kidney | 13 | 2023 | 1495 | 1.000 |
Why?
| | Urination | 5 | 2025 | 48 | 1.000 |
Why?
| | Lactams, Macrocyclic | 2 | 2017 | 51 | 0.980 |
Why?
| | Benzoquinones | 2 | 2017 | 47 | 0.970 |
Why?
| | Urologic Surgical Procedures, Male | 3 | 2022 | 32 | 0.970 |
Why?
| | Urinary Tract | 5 | 2016 | 48 | 0.950 |
Why?
| | Infant | 51 | 2025 | 10034 | 0.930 |
Why?
| | Postoperative Complications | 20 | 2024 | 2919 | 0.920 |
Why?
| | Hernias, Diaphragmatic, Congenital | 15 | 1998 | 219 | 0.890 |
Why?
| | Cystostomy | 4 | 2025 | 11 | 0.890 |
Why?
| | Hernia, Diaphragmatic | 13 | 2000 | 67 | 0.860 |
Why?
| | Urinary Incontinence | 6 | 2015 | 64 | 0.850 |
Why?
| | Child | 66 | 2025 | 22633 | 0.840 |
Why?
| | Muscle, Smooth | 5 | 2025 | 153 | 0.780 |
Why?
| | Tocotrienols | 1 | 2023 | 3 | 0.780 |
Why?
| | Child, Preschool | 46 | 2025 | 11787 | 0.780 |
Why?
| | Cryptorchidism | 5 | 2024 | 17 | 0.770 |
Why?
| | Reoperation | 11 | 2018 | 630 | 0.770 |
Why?
| | Urologic Diseases | 5 | 2018 | 40 | 0.770 |
Why?
| | Male | 95 | 2025 | 72315 | 0.760 |
Why?
| | Ureter | 6 | 2019 | 36 | 0.760 |
Why?
| | Fecal Incontinence | 7 | 2025 | 91 | 0.730 |
Why?
| | Rectum | 7 | 2023 | 180 | 0.720 |
Why?
| | Penis | 3 | 2019 | 32 | 0.720 |
Why?
| | Postoperative Care | 3 | 2019 | 288 | 0.710 |
Why?
| | Humans | 147 | 2025 | 144759 | 0.710 |
Why?
| | Urinary Bladder Diseases | 4 | 2022 | 18 | 0.700 |
Why?
| | Vagina | 4 | 2025 | 201 | 0.700 |
Why?
| | Disorders of Sex Development | 2 | 2019 | 40 | 0.690 |
Why?
| | Kidney Pelvis | 4 | 2022 | 21 | 0.680 |
Why?
| | Anger | 1 | 2021 | 60 | 0.670 |
Why?
| | Receptor, Serotonin, 5-HT2A | 1 | 2021 | 18 | 0.660 |
Why?
| | Anal Canal | 6 | 2023 | 102 | 0.660 |
Why?
| | TRPV Cation Channels | 1 | 2021 | 43 | 0.650 |
Why?
| | Calcium Channels | 1 | 2021 | 154 | 0.620 |
Why?
| | Female | 91 | 2025 | 78271 | 0.610 |
Why?
| | Constipation | 1 | 2021 | 98 | 0.610 |
Why?
| | Muscle Contraction | 4 | 2025 | 429 | 0.600 |
Why?
| | Retrospective Studies | 47 | 2025 | 17066 | 0.600 |
Why?
| | Ultrasonography, Prenatal | 8 | 2014 | 294 | 0.580 |
Why?
| | Laparoscopy | 7 | 2024 | 475 | 0.570 |
Why?
| | Follow-Up Studies | 23 | 2018 | 5408 | 0.570 |
Why?
| | Receptors, Purinergic P2X1 | 1 | 2018 | 3 | 0.570 |
Why?
| | Cholinergic Fibers | 1 | 2018 | 19 | 0.570 |
Why?
| | Receptors, Muscarinic | 1 | 2018 | 20 | 0.570 |
Why?
| | Photography | 1 | 2019 | 115 | 0.560 |
Why?
| | Intestine, Large | 1 | 2018 | 14 | 0.560 |
Why?
| | Genitalia, Female | 2 | 2018 | 42 | 0.550 |
Why?
| | Vesico-Ureteral Reflux | 4 | 2012 | 38 | 0.540 |
Why?
| | Urination Disorders | 2 | 2015 | 15 | 0.520 |
Why?
| | Anesthetics, Local | 2 | 2015 | 100 | 0.510 |
Why?
| | Pulmonary Surfactants | 9 | 2000 | 102 | 0.510 |
Why?
| | Preoperative Care | 3 | 2011 | 379 | 0.500 |
Why?
| | Treatment Outcome | 24 | 2025 | 11679 | 0.490 |
Why?
| | Bladder Exstrophy | 6 | 2007 | 18 | 0.480 |
Why?
| | Perioperative Care | 2 | 2018 | 231 | 0.480 |
Why?
| | Clitoris | 1 | 2016 | 9 | 0.470 |
Why?
| | Intermittent Urethral Catheterization | 1 | 2015 | 4 | 0.460 |
Why?
| | Surgical Wound Infection | 2 | 2025 | 316 | 0.450 |
Why?
| | Infant, Newborn | 28 | 2020 | 6429 | 0.440 |
Why?
| | Ventriculoperitoneal Shunt | 2 | 2011 | 44 | 0.430 |
Why?
| | Nephrectomy | 5 | 2009 | 158 | 0.420 |
Why?
| | Gastrointestinal Diseases | 1 | 2016 | 216 | 0.410 |
Why?
| | Infusion Pumps | 1 | 2013 | 32 | 0.410 |
Why?
| | Vincristine | 3 | 2024 | 140 | 0.410 |
Why?
| | Prospective Studies | 15 | 2025 | 7990 | 0.400 |
Why?
| | Recovery of Function | 1 | 2018 | 707 | 0.400 |
Why?
| | Colon | 4 | 2023 | 304 | 0.390 |
Why?
| | Creatinine | 1 | 2015 | 506 | 0.390 |
Why?
| | Animals | 31 | 2025 | 38058 | 0.390 |
Why?
| | Pediatrics | 4 | 2024 | 1114 | 0.380 |
Why?
| | Paraphimosis | 1 | 2012 | 1 | 0.380 |
Why?
| | Enema | 2 | 2006 | 46 | 0.380 |
Why?
| | Adolescent | 41 | 2025 | 22428 | 0.370 |
Why?
| | Abnormalities, Multiple | 5 | 2006 | 197 | 0.370 |
Why?
| | Cadherins | 1 | 2014 | 201 | 0.370 |
Why?
| | Bandages | 1 | 2012 | 42 | 0.360 |
Why?
| | Diagnostic Techniques, Urological | 1 | 2012 | 5 | 0.360 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 297 | 0.350 |
Why?
| | Radioisotope Renography | 1 | 2011 | 4 | 0.350 |
Why?
| | Edema | 1 | 2012 | 124 | 0.350 |
Why?
| | Incidence | 7 | 2024 | 2879 | 0.340 |
Why?
| | Surgical Sponges | 1 | 2011 | 5 | 0.340 |
Why?
| | Age Factors | 9 | 2019 | 3333 | 0.340 |
Why?
| | Dissection | 1 | 2011 | 56 | 0.330 |
Why?
| | Analgesics, Opioid | 2 | 2020 | 1143 | 0.330 |
Why?
| | Guideline Adherence | 1 | 2015 | 589 | 0.330 |
Why?
| | Disease Models, Animal | 11 | 2025 | 4557 | 0.320 |
Why?
| | Stents | 1 | 2014 | 556 | 0.320 |
Why?
| | Transition to Adult Care | 2 | 2023 | 96 | 0.300 |
Why?
| | Mice, Inbred C57BL | 5 | 2021 | 5992 | 0.300 |
Why?
| | Wilms Tumor | 3 | 2017 | 85 | 0.300 |
Why?
| | Prenatal Diagnosis | 6 | 2007 | 195 | 0.300 |
Why?
| | Neurosurgical Procedures | 1 | 2011 | 202 | 0.300 |
Why?
| | Sexual Dysfunction, Physiological | 2 | 2009 | 74 | 0.290 |
Why?
| | Cystitis | 1 | 2009 | 23 | 0.290 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2015 | 653 | 0.290 |
Why?
| | Mice | 14 | 2025 | 18339 | 0.290 |
Why?
| | Fetal Diseases | 3 | 2007 | 191 | 0.290 |
Why?
| | Registries | 1 | 2018 | 2385 | 0.290 |
Why?
| | Urethral Diseases | 3 | 2020 | 18 | 0.280 |
Why?
| | Vascular Endothelial Growth Factor A | 3 | 2011 | 557 | 0.280 |
Why?
| | Ileum | 2 | 2006 | 111 | 0.270 |
Why?
| | Ureterocele | 1 | 2007 | 7 | 0.270 |
Why?
| | Adrenal Hyperplasia, Congenital | 2 | 2005 | 39 | 0.270 |
Why?
| | Signal Transduction | 2 | 2021 | 5226 | 0.270 |
Why?
| | Doxorubicin | 2 | 2021 | 397 | 0.270 |
Why?
| | Digestive System Abnormalities | 2 | 2004 | 15 | 0.270 |
Why?
| | Pulmonary Gas Exchange | 4 | 1998 | 119 | 0.270 |
Why?
| | Colon, Sigmoid | 5 | 2021 | 21 | 0.250 |
Why?
| | Cathartics | 1 | 2006 | 15 | 0.250 |
Why?
| | Urography | 1 | 2006 | 19 | 0.250 |
Why?
| | Pelvis | 2 | 2025 | 124 | 0.250 |
Why?
| | Urinary Bladder Fistula | 2 | 2022 | 11 | 0.250 |
Why?
| | Robotic Surgical Procedures | 2 | 2022 | 182 | 0.250 |
Why?
| | Congenital Abnormalities | 3 | 2020 | 104 | 0.240 |
Why?
| | Vesicovaginal Fistula | 1 | 2005 | 5 | 0.230 |
Why?
| | Kidney Function Tests | 4 | 2015 | 157 | 0.230 |
Why?
| | Negative-Pressure Wound Therapy | 1 | 2025 | 28 | 0.220 |
Why?
| | Pain Measurement | 3 | 2015 | 552 | 0.220 |
Why?
| | Animals, Newborn | 6 | 2018 | 902 | 0.210 |
Why?
| | Postnatal Care | 2 | 2015 | 72 | 0.210 |
Why?
| | Colorectal Neoplasms | 2 | 2022 | 845 | 0.210 |
Why?
| | Kidney Neoplasms | 2 | 2009 | 412 | 0.210 |
Why?
| | Orchiopexy | 2 | 2024 | 7 | 0.210 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2004 | 58 | 0.210 |
Why?
| | Psychosocial Support Systems | 1 | 2023 | 16 | 0.200 |
Why?
| | Hemorrhage | 1 | 2009 | 809 | 0.200 |
Why?
| | Endometriosis | 1 | 2024 | 57 | 0.200 |
Why?
| | Peripheral Nervous System Diseases | 2 | 2022 | 133 | 0.200 |
Why?
| | Urinary Diversion | 4 | 2015 | 13 | 0.200 |
Why?
| | Mass Screening | 1 | 2012 | 1347 | 0.190 |
Why?
| | Fetus | 1 | 2007 | 803 | 0.190 |
Why?
| | Prognosis | 5 | 2018 | 4282 | 0.190 |
Why?
| | Sacrum | 1 | 2003 | 78 | 0.190 |
Why?
| | Imaging, Three-Dimensional | 1 | 2006 | 583 | 0.190 |
Why?
| | Surgical Flaps | 1 | 2003 | 142 | 0.180 |
Why?
| | Propensity Score | 1 | 2024 | 367 | 0.180 |
Why?
| | Delphi Technique | 1 | 2024 | 329 | 0.180 |
Why?
| | Length of Stay | 5 | 2023 | 1337 | 0.180 |
Why?
| | Ultrasonography | 4 | 2015 | 770 | 0.180 |
Why?
| | Muscle Development | 1 | 2003 | 116 | 0.180 |
Why?
| | Risk Assessment | 6 | 2024 | 3671 | 0.180 |
Why?
| | Kidney Calices | 1 | 2001 | 1 | 0.180 |
Why?
| | Lung | 6 | 1998 | 4109 | 0.180 |
Why?
| | Analgesia | 2 | 2020 | 105 | 0.180 |
Why?
| | Cell Hypoxia | 3 | 2014 | 247 | 0.180 |
Why?
| | Sheep | 11 | 1998 | 880 | 0.170 |
Why?
| | Extracellular Matrix Proteins | 1 | 2003 | 158 | 0.170 |
Why?
| | Spinal Cord Injuries | 1 | 2025 | 240 | 0.170 |
Why?
| | Digestive System Surgical Procedures | 2 | 2019 | 109 | 0.170 |
Why?
| | Catheterization | 3 | 2013 | 183 | 0.170 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2024 | 338 | 0.170 |
Why?
| | Testicular Neoplasms | 2 | 2019 | 113 | 0.170 |
Why?
| | Sex Factors | 5 | 2024 | 2112 | 0.170 |
Why?
| | Pilot Projects | 3 | 2025 | 1886 | 0.170 |
Why?
| | Postoperative Nausea and Vomiting | 1 | 2020 | 25 | 0.160 |
Why?
| | Robotics | 1 | 2022 | 87 | 0.160 |
Why?
| | Hydrocephalus | 2 | 2011 | 111 | 0.160 |
Why?
| | Administration, Oral | 1 | 2023 | 847 | 0.160 |
Why?
| | Prune Belly Syndrome | 2 | 2011 | 8 | 0.160 |
Why?
| | Pregnancy Outcome | 2 | 2022 | 476 | 0.160 |
Why?
| | Intestinal Obstruction | 3 | 1997 | 56 | 0.160 |
Why?
| | Gastrostomy | 2 | 1999 | 130 | 0.160 |
Why?
| | Cell Division | 1 | 2002 | 766 | 0.160 |
Why?
| | Colitis, Ulcerative | 2 | 2021 | 147 | 0.150 |
Why?
| | Perinatology | 1 | 1999 | 12 | 0.150 |
Why?
| | Hypertrophy | 2 | 2019 | 127 | 0.150 |
Why?
| | Smooth Muscle Myosins | 1 | 2019 | 7 | 0.150 |
Why?
| | Reflex | 2 | 2018 | 69 | 0.150 |
Why?
| | Muscle Relaxation | 1 | 2019 | 28 | 0.150 |
Why?
| | Myosin Light Chains | 1 | 2019 | 28 | 0.150 |
Why?
| | Atlases as Topic | 1 | 2019 | 11 | 0.150 |
Why?
| | Nephrostomy, Percutaneous | 1 | 1999 | 11 | 0.150 |
Why?
| | Nephrology Nursing | 1 | 2019 | 15 | 0.150 |
Why?
| | Nephrology | 1 | 1999 | 60 | 0.150 |
Why?
| | Emotions | 1 | 2024 | 578 | 0.140 |
Why?
| | Pediatric Nursing | 1 | 2019 | 44 | 0.140 |
Why?
| | Anxiety, Separation | 1 | 2018 | 11 | 0.140 |
Why?
| | Diet | 1 | 2006 | 1273 | 0.140 |
Why?
| | Maternal Deprivation | 1 | 2018 | 16 | 0.140 |
Why?
| | Umbilicus | 1 | 1998 | 17 | 0.140 |
Why?
| | Twins, Conjoined | 1 | 1998 | 6 | 0.140 |
Why?
| | Extracellular Matrix | 1 | 2003 | 553 | 0.140 |
Why?
| | Phospholipids | 2 | 1997 | 213 | 0.140 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2019 | 139 | 0.140 |
Why?
| | Glomerular Filtration Rate | 3 | 2015 | 760 | 0.140 |
Why?
| | Intestinal Pseudo-Obstruction | 2 | 1997 | 8 | 0.140 |
Why?
| | Reference Values | 2 | 2018 | 797 | 0.140 |
Why?
| | Diagnostic Errors | 1 | 2019 | 175 | 0.140 |
Why?
| | Phosphatidylcholines | 2 | 1997 | 131 | 0.130 |
Why?
| | Kidney Diseases | 4 | 2009 | 427 | 0.130 |
Why?
| | Medical Errors | 1 | 2019 | 118 | 0.130 |
Why?
| | Young Adult | 10 | 2025 | 14105 | 0.130 |
Why?
| | Tertiary Care Centers | 1 | 2019 | 189 | 0.130 |
Why?
| | Urinary Catheterization | 2 | 2001 | 33 | 0.130 |
Why?
| | Genitalia, Male | 1 | 1997 | 11 | 0.130 |
Why?
| | Genitalia | 3 | 2019 | 34 | 0.130 |
Why?
| | Urologic Neoplasms | 1 | 2017 | 31 | 0.130 |
Why?
| | Cholestasis, Extrahepatic | 1 | 1997 | 3 | 0.130 |
Why?
| | Peptic Ulcer Hemorrhage | 1 | 1997 | 5 | 0.130 |
Why?
| | Peptic Ulcer Perforation | 1 | 1997 | 4 | 0.130 |
Why?
| | Duodenal Ulcer | 1 | 1997 | 12 | 0.130 |
Why?
| | Time Factors | 6 | 2019 | 7173 | 0.130 |
Why?
| | Cholelithiasis | 1 | 1997 | 36 | 0.130 |
Why?
| | Case-Control Studies | 3 | 2020 | 3604 | 0.130 |
Why?
| | Health Services Needs and Demand | 1 | 2019 | 280 | 0.130 |
Why?
| | Gallstones | 1 | 1997 | 35 | 0.130 |
Why?
| | Decision Making | 1 | 2024 | 975 | 0.130 |
Why?
| | Informed Consent | 1 | 1998 | 198 | 0.120 |
Why?
| | Postoperative Period | 1 | 2018 | 354 | 0.120 |
Why?
| | Algorithms | 3 | 2018 | 1837 | 0.120 |
Why?
| | Adult | 17 | 2024 | 40449 | 0.120 |
Why?
| | Acute Kidney Injury | 1 | 2024 | 865 | 0.120 |
Why?
| | Cancer Survivors | 1 | 2021 | 327 | 0.120 |
Why?
| | Vulva | 1 | 2016 | 23 | 0.120 |
Why?
| | Gene Expression Profiling | 1 | 2023 | 1782 | 0.120 |
Why?
| | Urinary Bladder Neoplasms | 2 | 2017 | 255 | 0.120 |
Why?
| | Endoscopy | 1 | 1998 | 316 | 0.110 |
Why?
| | Caregivers | 1 | 2024 | 1049 | 0.110 |
Why?
| | Patient Safety | 1 | 2019 | 347 | 0.110 |
Why?
| | Fluorocarbons | 1 | 1997 | 143 | 0.110 |
Why?
| | Phosphatidylglycerols | 1 | 1995 | 18 | 0.110 |
Why?
| | Sphingomyelins | 1 | 1995 | 22 | 0.110 |
Why?
| | Pneumothorax | 1 | 1995 | 51 | 0.110 |
Why?
| | Attitude to Health | 1 | 1998 | 436 | 0.110 |
Why?
| | Infusion Pumps, Implantable | 1 | 2015 | 26 | 0.110 |
Why?
| | Toothbrushing | 1 | 1994 | 5 | 0.110 |
Why?
| | Outpatients | 1 | 2019 | 442 | 0.110 |
Why?
| | Lung Compliance | 2 | 1995 | 42 | 0.110 |
Why?
| | Gynecologic Surgical Procedures | 3 | 2021 | 64 | 0.110 |
Why?
| | Testis | 2 | 2023 | 163 | 0.110 |
Why?
| | Risk Factors | 3 | 2018 | 10779 | 0.110 |
Why?
| | Pregnancy | 11 | 2022 | 7190 | 0.110 |
Why?
| | Surveys and Questionnaires | 6 | 2024 | 6048 | 0.110 |
Why?
| | Bulimia | 1 | 1994 | 35 | 0.110 |
Why?
| | Desmin | 2 | 2006 | 24 | 0.110 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1539 | 0.110 |
Why?
| | Amniotic Fluid | 1 | 1995 | 79 | 0.110 |
Why?
| | Bone and Bones | 1 | 1997 | 314 | 0.110 |
Why?
| | Scrotum | 2 | 2007 | 24 | 0.110 |
Why?
| | Appendix | 3 | 2001 | 31 | 0.110 |
Why?
| | Medical Oncology | 1 | 2017 | 332 | 0.100 |
Why?
| | Triiodothyronine | 1 | 1994 | 54 | 0.100 |
Why?
| | Laparotomy | 1 | 1994 | 112 | 0.100 |
Why?
| | Organ Size | 2 | 2014 | 463 | 0.100 |
Why?
| | Sensitivity and Specificity | 3 | 2011 | 1985 | 0.100 |
Why?
| | Statistics, Nonparametric | 1 | 2015 | 427 | 0.100 |
Why?
| | Meconium | 1 | 1993 | 7 | 0.100 |
Why?
| | Infusions, Intravenous | 1 | 2015 | 423 | 0.100 |
Why?
| | Cell Differentiation | 1 | 2002 | 2050 | 0.100 |
Why?
| | Foreign Bodies | 1 | 1994 | 107 | 0.100 |
Why?
| | Phenyl Ethers | 1 | 1993 | 5 | 0.100 |
Why?
| | ROC Curve | 2 | 2015 | 614 | 0.100 |
Why?
| | Anastomosis, Surgical | 5 | 2020 | 157 | 0.100 |
Why?
| | Foreign-Body Migration | 2 | 2011 | 32 | 0.100 |
Why?
| | Nitric Oxide | 2 | 1997 | 897 | 0.100 |
Why?
| | Apoptosis | 1 | 2002 | 2430 | 0.100 |
Why?
| | Perineum | 2 | 2019 | 37 | 0.100 |
Why?
| | Logistic Models | 1 | 2018 | 2117 | 0.090 |
Why?
| | Foreskin | 1 | 2012 | 5 | 0.090 |
Why?
| | Syndrome | 2 | 2007 | 380 | 0.090 |
Why?
| | Infant Food | 1 | 1993 | 64 | 0.090 |
Why?
| | Epispadias | 2 | 2002 | 4 | 0.090 |
Why?
| | Respiration, Artificial | 1 | 1997 | 708 | 0.090 |
Why?
| | Fertility | 2 | 2022 | 168 | 0.090 |
Why?
| | Comorbidity | 2 | 2016 | 1658 | 0.090 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2014 | 219 | 0.090 |
Why?
| | Receptor, Muscarinic M3 | 1 | 2011 | 3 | 0.090 |
Why?
| | Hydrocortisone | 1 | 1994 | 304 | 0.090 |
Why?
| | Fetal Blood | 1 | 1994 | 342 | 0.090 |
Why?
| | Metabolism, Inborn Errors | 1 | 2011 | 42 | 0.090 |
Why?
| | Shock | 1 | 1993 | 108 | 0.090 |
Why?
| | Gestational Age | 4 | 2004 | 975 | 0.080 |
Why?
| | Severity of Illness Index | 2 | 2016 | 2925 | 0.080 |
Why?
| | Ovarian Neoplasms | 2 | 2024 | 586 | 0.080 |
Why?
| | Predictive Value of Tests | 2 | 2012 | 2115 | 0.080 |
Why?
| | Hernia, Ventral | 1 | 2010 | 22 | 0.080 |
Why?
| | Pain Management | 1 | 2013 | 405 | 0.080 |
Why?
| | Parents | 1 | 1998 | 1403 | 0.080 |
Why?
| | Ischemia | 1 | 1993 | 421 | 0.070 |
Why?
| | Immunohistochemistry | 4 | 2011 | 1716 | 0.070 |
Why?
| | Intestines | 3 | 2020 | 358 | 0.070 |
Why?
| | Urinary Reservoirs, Continent | 2 | 2016 | 4 | 0.070 |
Why?
| | Genetic Therapy | 1 | 2011 | 313 | 0.070 |
Why?
| | Acute Disease | 1 | 2012 | 1030 | 0.070 |
Why?
| | Campomelic Dysplasia | 1 | 2009 | 2 | 0.070 |
Why?
| | Dysgerminoma | 1 | 2009 | 7 | 0.070 |
Why?
| | BK Virus | 1 | 2009 | 17 | 0.070 |
Why?
| | RNA, Small Interfering | 1 | 2011 | 635 | 0.070 |
Why?
| | Constriction, Pathologic | 2 | 2021 | 248 | 0.070 |
Why?
| | Urolithiasis | 1 | 2009 | 11 | 0.070 |
Why?
| | Polyomavirus Infections | 1 | 2009 | 29 | 0.070 |
Why?
| | Hyperbaric Oxygenation | 1 | 2009 | 39 | 0.070 |
Why?
| | Tumor Virus Infections | 1 | 2009 | 49 | 0.070 |
Why?
| | SOX9 Transcription Factor | 1 | 2009 | 28 | 0.070 |
Why?
| | Databases, Factual | 3 | 2019 | 1486 | 0.070 |
Why?
| | Bronchoalveolar Lavage Fluid | 3 | 1997 | 636 | 0.070 |
Why?
| | Ureterostomy | 1 | 2007 | 2 | 0.070 |
Why?
| | Evidence-Based Medicine | 1 | 2012 | 732 | 0.070 |
Why?
| | Bone Marrow Transplantation | 1 | 2009 | 294 | 0.070 |
Why?
| | Cohort Studies | 2 | 2016 | 5960 | 0.070 |
Why?
| | Disease Progression | 1 | 2015 | 2847 | 0.060 |
Why?
| | Calcinosis | 1 | 2009 | 234 | 0.060 |
Why?
| | Urogenital Neoplasms | 1 | 2006 | 5 | 0.060 |
Why?
| | Myogenin | 1 | 2006 | 15 | 0.060 |
Why?
| | Organ Culture Techniques | 1 | 2007 | 154 | 0.060 |
Why?
| | Rhabdomyosarcoma, Embryonal | 1 | 2006 | 16 | 0.060 |
Why?
| | Pulmonary Artery | 4 | 1997 | 1134 | 0.060 |
Why?
| | Analysis of Variance | 3 | 2009 | 1306 | 0.060 |
Why?
| | Hematocolpos | 1 | 2005 | 3 | 0.060 |
Why?
| | Mullerian Ducts | 1 | 2025 | 17 | 0.060 |
Why?
| | Neoplasms | 1 | 2021 | 2875 | 0.060 |
Why?
| | Colonic Neoplasms | 1 | 2007 | 259 | 0.060 |
Why?
| | Nanoparticles | 1 | 2011 | 519 | 0.060 |
Why?
| | Fetal Organ Maturity | 2 | 1995 | 13 | 0.050 |
Why?
| | Liver Neoplasms | 1 | 2011 | 780 | 0.050 |
Why?
| | Malabsorption Syndromes | 1 | 2004 | 16 | 0.050 |
Why?
| | Defecation | 1 | 2004 | 18 | 0.050 |
Why?
| | Gonadoblastoma | 1 | 2024 | 7 | 0.050 |
Why?
| | Nutritional Support | 1 | 2004 | 39 | 0.050 |
Why?
| | Rabbits | 2 | 1996 | 648 | 0.050 |
Why?
| | Menstruation Disturbances | 1 | 2003 | 13 | 0.050 |
Why?
| | Coitus | 1 | 2003 | 23 | 0.050 |
Why?
| | Practice Guidelines as Topic | 1 | 2012 | 1560 | 0.050 |
Why?
| | Salvage Therapy | 1 | 2004 | 162 | 0.050 |
Why?
| | Urologists | 1 | 2023 | 17 | 0.050 |
Why?
| | Steroid 21-Hydroxylase | 1 | 2003 | 27 | 0.050 |
Why?
| | Urethral Obstruction | 1 | 2003 | 8 | 0.050 |
Why?
| | Extravasation of Diagnostic and Therapeutic Materials | 1 | 2003 | 19 | 0.050 |
Why?
| | Methyl Green | 1 | 2003 | 1 | 0.050 |
Why?
| | Eosine Yellowish-(YS) | 1 | 2003 | 10 | 0.050 |
Why?
| | Colostomy | 3 | 2004 | 28 | 0.050 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2024 | 177 | 0.050 |
Why?
| | Decision Support Techniques | 1 | 2007 | 456 | 0.050 |
Why?
| | Ascites | 1 | 2003 | 49 | 0.050 |
Why?
| | Urine | 1 | 2003 | 62 | 0.050 |
Why?
| | Azo Compounds | 1 | 2003 | 30 | 0.050 |
Why?
| | Biomarkers | 1 | 2014 | 4271 | 0.050 |
Why?
| | Urothelium | 1 | 2003 | 33 | 0.050 |
Why?
| | Mast Cells | 1 | 2024 | 146 | 0.050 |
Why?
| | Pain Threshold | 1 | 2002 | 73 | 0.050 |
Why?
| | Mandelic Acids | 1 | 2002 | 2 | 0.050 |
Why?
| | Erectile Dysfunction | 1 | 2022 | 38 | 0.050 |
Why?
| | Urinary Sphincter, Artificial | 1 | 2002 | 7 | 0.050 |
Why?
| | Puberty | 1 | 2003 | 140 | 0.050 |
Why?
| | Fatal Outcome | 2 | 2007 | 307 | 0.050 |
Why?
| | Endocrinology | 1 | 2003 | 77 | 0.050 |
Why?
| | Cholinergic Antagonists | 1 | 2002 | 23 | 0.050 |
Why?
| | Observer Variation | 1 | 2003 | 355 | 0.040 |
Why?
| | Oligohydramnios | 1 | 2002 | 12 | 0.040 |
Why?
| | Mucous Membrane | 1 | 2003 | 127 | 0.040 |
Why?
| | Proliferating Cell Nuclear Antigen | 1 | 2002 | 49 | 0.040 |
Why?
| | Pelvic Neoplasms | 1 | 2002 | 24 | 0.040 |
Why?
| | Dilatation, Pathologic | 2 | 2001 | 62 | 0.040 |
Why?
| | Blood Pressure | 4 | 1997 | 1769 | 0.040 |
Why?
| | Ureteral Diseases | 1 | 2001 | 4 | 0.040 |
Why?
| | Reproducibility of Results | 2 | 2015 | 3409 | 0.040 |
Why?
| | Pulmonary Surfactant-Associated Proteins | 2 | 2000 | 9 | 0.040 |
Why?
| | Proteolipids | 2 | 2000 | 28 | 0.040 |
Why?
| | Learning Curve | 1 | 2022 | 70 | 0.040 |
Why?
| | Transplantation, Autologous | 1 | 2002 | 290 | 0.040 |
Why?
| | Cysts | 1 | 2002 | 111 | 0.040 |
Why?
| | Interleukin-2 | 1 | 2022 | 437 | 0.040 |
Why?
| | Urinary Fistula | 1 | 2000 | 9 | 0.040 |
Why?
| | Radiography | 1 | 2003 | 844 | 0.040 |
Why?
| | Adenocarcinoma | 1 | 2007 | 928 | 0.040 |
Why?
| | Sexual Dysfunctions, Psychological | 1 | 2000 | 30 | 0.040 |
Why?
| | Blotting, Western | 1 | 2003 | 1187 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2024 | 2027 | 0.040 |
Why?
| | Jejunal Diseases | 1 | 1999 | 6 | 0.040 |
Why?
| | Gastric Fistula | 1 | 1999 | 9 | 0.040 |
Why?
| | Intestinal Fistula | 1 | 1999 | 17 | 0.040 |
Why?
| | Tomography, X-Ray Computed | 2 | 2007 | 2730 | 0.040 |
Why?
| | Myosin-Light-Chain Kinase | 1 | 2019 | 19 | 0.040 |
Why?
| | Large-Conductance Calcium-Activated Potassium Channel beta Subunits | 1 | 2019 | 8 | 0.040 |
Why?
| | Actins | 1 | 2002 | 425 | 0.040 |
Why?
| | Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2019 | 10 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2023 | 1095 | 0.040 |
Why?
| | Multicenter Studies as Topic | 1 | 2020 | 405 | 0.040 |
Why?
| | Pulmonary Alveoli | 2 | 2000 | 383 | 0.040 |
Why?
| | Digestive System Diseases | 1 | 1998 | 27 | 0.040 |
Why?
| | Biological Variation, Population | 1 | 2018 | 20 | 0.040 |
Why?
| | Intubation, Gastrointestinal | 1 | 1999 | 82 | 0.040 |
Why?
| | Genital Diseases, Female | 1 | 2018 | 31 | 0.040 |
Why?
| | Rectal Prolapse | 1 | 2018 | 24 | 0.040 |
Why?
| | Counseling | 1 | 2002 | 408 | 0.030 |
Why?
| | Cecostomy | 1 | 1998 | 3 | 0.030 |
Why?
| | Surgical Stomas | 1 | 1998 | 10 | 0.030 |
Why?
| | Middle Aged | 6 | 2024 | 35875 | 0.030 |
Why?
| | Patient Reported Outcome Measures | 1 | 2022 | 488 | 0.030 |
Why?
| | Surgical Mesh | 1 | 1998 | 50 | 0.030 |
Why?
| | Drainage | 1 | 1999 | 185 | 0.030 |
Why?
| | Mutation | 1 | 2009 | 4089 | 0.030 |
Why?
| | Sigmoid Diseases | 1 | 1997 | 14 | 0.030 |
Why?
| | Blood Gas Analysis | 1 | 1997 | 83 | 0.030 |
Why?
| | Cardiology Service, Hospital | 1 | 1997 | 29 | 0.030 |
Why?
| | Survival Analysis | 2 | 2017 | 1382 | 0.030 |
Why?
| | Sex Characteristics | 1 | 2003 | 790 | 0.030 |
Why?
| | Quality of Life | 1 | 2009 | 3185 | 0.030 |
Why?
| | Capillaries | 1 | 1998 | 124 | 0.030 |
Why?
| | Ileal Diseases | 1 | 1996 | 14 | 0.030 |
Why?
| | Rhabdomyosarcoma | 1 | 2017 | 64 | 0.030 |
Why?
| | Ampulla of Vater | 1 | 1997 | 39 | 0.030 |
Why?
| | Stomach | 1 | 1997 | 109 | 0.030 |
Why?
| | Duodenum | 1 | 1997 | 77 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2019 | 1253 | 0.030 |
Why?
| | Rats | 2 | 1996 | 5597 | 0.030 |
Why?
| | Teratoma | 1 | 2017 | 120 | 0.030 |
Why?
| | Persistent Fetal Circulation Syndrome | 2 | 1995 | 138 | 0.030 |
Why?
| | Barrett Esophagus | 1 | 1999 | 165 | 0.030 |
Why?
| | Umbilical Cord | 1 | 1996 | 91 | 0.030 |
Why?
| | Rectal Neoplasms | 2 | 1998 | 156 | 0.030 |
Why?
| | Collagen | 2 | 1995 | 456 | 0.030 |
Why?
| | Operative Time | 1 | 2016 | 175 | 0.030 |
Why?
| | Clinical Protocols | 1 | 1997 | 282 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2020 | 1053 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2017 | 769 | 0.030 |
Why?
| | Wound Healing | 1 | 1998 | 351 | 0.030 |
Why?
| | Cross-Sectional Studies | 2 | 2024 | 5868 | 0.030 |
Why?
| | NADPH Dehydrogenase | 1 | 1995 | 6 | 0.030 |
Why?
| | Amino Acid Oxidoreductases | 1 | 1995 | 19 | 0.030 |
Why?
| | Tunica Intima | 1 | 1995 | 79 | 0.030 |
Why?
| | Phosphorylation | 1 | 2019 | 1732 | 0.030 |
Why?
| | Proteins | 3 | 1995 | 1021 | 0.030 |
Why?
| | Total Lung Capacity | 1 | 1994 | 29 | 0.030 |
Why?
| | Bupivacaine | 1 | 1994 | 38 | 0.030 |
Why?
| | Swine | 1 | 1996 | 833 | 0.030 |
Why?
| | Thoracotomy | 1 | 1994 | 83 | 0.030 |
Why?
| | Endothelins | 1 | 1994 | 63 | 0.030 |
Why?
| | Heart Diseases | 1 | 1997 | 349 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 1996 | 621 | 0.030 |
Why?
| | United States | 1 | 2011 | 15966 | 0.020 |
Why?
| | Mothers | 1 | 2020 | 775 | 0.020 |
Why?
| | Sigmoid Neoplasms | 1 | 1993 | 5 | 0.020 |
Why?
| | Aged, 80 and over | 2 | 2024 | 8265 | 0.020 |
Why?
| | Hypertonic Solutions | 1 | 1993 | 7 | 0.020 |
Why?
| | Disease Management | 1 | 2017 | 645 | 0.020 |
Why?
| | Gangrene | 1 | 1993 | 11 | 0.020 |
Why?
| | Ileostomy | 2 | 2004 | 25 | 0.020 |
Why?
| | Product Labeling | 1 | 1993 | 11 | 0.020 |
Why?
| | Recurrence | 1 | 1995 | 1135 | 0.020 |
Why?
| | INDEL Mutation | 1 | 2011 | 19 | 0.020 |
Why?
| | Frameshift Mutation | 1 | 2011 | 32 | 0.020 |
Why?
| | Necrosis | 1 | 1993 | 244 | 0.020 |
Why?
| | Consanguinity | 1 | 2011 | 49 | 0.020 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2011 | 157 | 0.020 |
Why?
| | beta-Galactosidase | 1 | 2011 | 77 | 0.020 |
Why?
| | Colorado | 2 | 2018 | 4564 | 0.020 |
Why?
| | Cardiac Surgical Procedures | 1 | 1997 | 609 | 0.020 |
Why?
| | Mice, SCID | 1 | 2011 | 369 | 0.020 |
Why?
| | Gene Transfer Techniques | 1 | 2011 | 185 | 0.020 |
Why?
| | Colitis | 1 | 1993 | 280 | 0.020 |
Why?
| | Patient Satisfaction | 1 | 2013 | 704 | 0.020 |
Why?
| | Extracorporeal Membrane Oxygenation | 3 | 2000 | 383 | 0.020 |
Why?
| | Base Sequence | 1 | 2011 | 2190 | 0.020 |
Why?
| | Tissue Survival | 1 | 2007 | 16 | 0.020 |
Why?
| | Cystectomy | 1 | 2007 | 41 | 0.020 |
Why?
| | Chronic Disease | 1 | 1993 | 1813 | 0.020 |
Why?
| | Aged | 3 | 2024 | 25913 | 0.020 |
Why?
| | Heart Defects, Congenital | 1 | 1995 | 914 | 0.020 |
Why?
| | Likelihood Functions | 1 | 2007 | 143 | 0.020 |
Why?
| | Microsurgery | 1 | 2007 | 72 | 0.020 |
Why?
| | Colectomy | 1 | 2007 | 107 | 0.020 |
Why?
| | Atrophy | 1 | 2007 | 201 | 0.020 |
Why?
| | Vaginal Neoplasms | 1 | 2006 | 19 | 0.020 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 2006 | 80 | 0.020 |
Why?
| | Models, Molecular | 1 | 2011 | 1618 | 0.020 |
Why?
| | Hypertension, Pulmonary | 1 | 1998 | 1980 | 0.010 |
Why?
| | Combined Modality Therapy | 1 | 2009 | 1266 | 0.010 |
Why?
| | Hydroxyproline | 2 | 1995 | 18 | 0.010 |
Why?
| | Elastin | 2 | 1995 | 79 | 0.010 |
Why?
| | Duodenal Obstruction | 1 | 2004 | 6 | 0.010 |
Why?
| | Intestinal Atresia | 1 | 2004 | 17 | 0.010 |
Why?
| | Parenteral Nutrition, Total | 1 | 2004 | 30 | 0.010 |
Why?
| | Short Bowel Syndrome | 1 | 2004 | 27 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2011 | 3121 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2011 | 3540 | 0.010 |
Why?
| | Diagnosis, Differential | 1 | 2007 | 1489 | 0.010 |
Why?
| | Enteritis | 1 | 2004 | 103 | 0.010 |
Why?
| | Gender Identity | 1 | 2003 | 121 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2006 | 1173 | 0.010 |
Why?
| | Europe | 1 | 2003 | 412 | 0.010 |
Why?
| | Aorta | 2 | 1995 | 429 | 0.010 |
Why?
| | Abdomen | 1 | 2002 | 141 | 0.010 |
Why?
| | Consensus | 1 | 2003 | 488 | 0.010 |
Why?
| | Hip Joint | 1 | 2002 | 172 | 0.010 |
Why?
| | Movement | 1 | 2002 | 293 | 0.010 |
Why?
| | Body Weight | 1 | 2004 | 976 | 0.010 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2000 | 106 | 0.010 |
Why?
| | Prostatic Neoplasms | 1 | 2006 | 974 | 0.010 |
Why?
| | Societies, Medical | 1 | 2003 | 887 | 0.010 |
Why?
| | Glycoproteins | 1 | 2000 | 355 | 0.010 |
Why?
| | Graft Survival | 1 | 2001 | 526 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2006 | 4154 | 0.010 |
Why?
| | DNA | 2 | 1995 | 1463 | 0.010 |
Why?
| | Compartment Syndromes | 1 | 1998 | 36 | 0.010 |
Why?
| | Leiomyoma | 1 | 1998 | 59 | 0.010 |
Why?
| | Blood-Air Barrier | 1 | 1998 | 12 | 0.010 |
Why?
| | Skin | 1 | 2002 | 755 | 0.010 |
Why?
| | Survival Rate | 1 | 2002 | 2089 | 0.010 |
Why?
| | Enteral Nutrition | 1 | 1999 | 216 | 0.010 |
Why?
| | Esophagoscopy | 1 | 1999 | 221 | 0.010 |
Why?
| | Constriction | 1 | 1996 | 47 | 0.010 |
Why?
| | Venous Thrombosis | 1 | 1998 | 194 | 0.010 |
Why?
| | Hospitals, Veterans | 1 | 1997 | 259 | 0.010 |
Why?
| | Kidney Failure, Chronic | 1 | 2002 | 598 | 0.010 |
Why?
| | Iatrogenic Disease | 1 | 1996 | 76 | 0.010 |
Why?
| | Venules | 1 | 1995 | 14 | 0.010 |
Why?
| | Heart Septum | 1 | 1995 | 28 | 0.010 |
Why?
| | Biopsy | 1 | 1999 | 1075 | 0.010 |
Why?
| | Arterioles | 1 | 1995 | 56 | 0.010 |
Why?
| | Ductus Arteriosus, Patent | 1 | 1995 | 50 | 0.010 |
Why?
| | Heart Septal Defects, Atrial | 1 | 1995 | 59 | 0.010 |
Why?
| | Pneumonia | 1 | 2000 | 631 | 0.010 |
Why?
| | Pleura | 1 | 1994 | 28 | 0.010 |
Why?
| | Heart Atria | 1 | 1995 | 144 | 0.010 |
Why?
| | Nitric Oxide Synthase | 1 | 1995 | 235 | 0.010 |
Why?
| | Bronchi | 1 | 1995 | 267 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1995 | 561 | 0.010 |
Why?
| | Administration, Inhalation | 1 | 1995 | 574 | 0.010 |
Why?
| | Image Processing, Computer-Assisted | 1 | 1998 | 780 | 0.010 |
Why?
| | Heparin | 1 | 1994 | 244 | 0.010 |
Why?
| | Hospital Mortality | 1 | 1997 | 1030 | 0.010 |
Why?
| | Echocardiography | 1 | 1994 | 652 | 0.010 |
Why?
| | Heart Ventricles | 1 | 1995 | 760 | 0.000 |
Why?
| | Cystic Fibrosis | 1 | 1999 | 1158 | 0.000 |
Why?
|
|
Wilcox's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|